<DOC>
	<DOC>NCT02911571</DOC>
	<brief_summary>This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment intention decisions in active Multiple Myeloma patients.</brief_summary>
	<brief_title>PRospective Multiple Myeloma Impact Study</brief_title>
	<detailed_description>This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment intention decisions in active MM patients. Eligible patients will have their tumor sample analyzed for the prognostic MMprofiler SKY92, several cytogenetic markers, gene expression markers, and gene expression clusters. A total of 250 patients will be enrolled from up to 7 US centers. Patients will be followed 5 years after diagnosis.</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms, Plasma Cell</mesh_term>
	<criteria>Potentially active and active multiple myeloma according to IMWG criteria Candidates for systemic treatment ECOG Performance Status &gt; 3 Tumor sample that fails QA or QC criteria for MMprofiler</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>